Sentences with phrase «multi-center study led»

December 6, 2011 Drug combination highly effective for newly diagnosed myeloma patients, study finds A three - drug combination treatment for the blood cancer multiple myeloma compares favorably to the best established therapy for newly diagnosed patients, according to a multi-center study led by Andrzej Jakubowiak, MD, PhD, professor of medicine and director of the multiple myeloma program at the University of Chicago Medical Center.

A multi-center study led by Fred Hutchinson Cancer Research Center has found that high - dose supplementation with both the trace element selenium and vitamin E increase the risk of high - grade prostate cancer.

High levels of two novel urinary biomarkers early in critical illness are associated with adverse long - term outcomes in patients with acute kidney injury (AKI), according to an international, multi-center study led by University of Pittsburgh School of Medicine Researchers.

Not exact matches

The generally accepted medical maxim that elevated HDL cholesterol (HDL - C) is «good» has been overturned by a multi-center, international study, led by researchers from the Perelman School of Medicine at the University of Pennsylvania.

Both adverse outcomes need to be studied further, according to Legro, who led a team that hosted the Chinese collaborators at Penn State College of Medicine for five weeks as the group wrote the protocol for the multi-center trial and participated in regular steering committee meetings overseeing the trial.

Those encouraging findings from the small - scale pilot study formed the basis for this multi-center clinical trial led by Carley and Zee.

In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutations.

The findings have led to the first primary vaccine study that we are conducting as a multi-center international trial.

Dr. Lanteri played the role of Study Coordinator for several multi-center studies including the Central Laboratory portion of the «Recipient Epidemiology and Donor Evaluation Study (REDS)- III» supported by the NHLBI and as one of the REDS - III investigators, she has led several REDS - III studies addressing a variety of questions on the safety of blood donations and transfusions from both the donor and the recipient points of view.